Incidence, Persistence, and Factors Associated With HPV Infection Among Male Adolescents With and Without Perinatally Acquired HIV Infection

被引:7
作者
Gatechompol, Sivaporn [1 ,2 ]
Teeratakulpisarn, Nipat [3 ]
Wittawatmongkol, Orasri [4 ]
Teeraananchai, Sirinya [1 ,5 ]
Kerr, Stephen J. [1 ,6 ]
Chalermchockcharoenkit, Amphan [4 ]
Thamkhantho, Manopchai [4 ]
Singtoroj, Thida [7 ]
Phanuphak, Nittaya [3 ]
Sohn, Annette H. [7 ]
Chokephaibulkit, Kulkanya [4 ]
机构
[1] Thai Red Cross Aids Res Ctr, HIV NAT, Bangkok, Thailand
[2] Chulalongkorn Univ, Fac Med, TB Res Unit, Bangkok, Thailand
[3] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand
[4] Mahidol Univ, Fac Med Siriraj Hosp, Bangkok, Thailand
[5] Kasetsart Univ, Fac Sci, Dept Stat, Bangkok, Thailand
[6] Chulalongkorn Univ, Fac Med, Biostat Excellence Ctr, Bangkok, Thailand
[7] TREAT Asia AmfAR Fdn AIDS Res, Bangkok, Thailand
基金
美国国家卫生研究院;
关键词
HIV; perinatal; human papillomavirus; incidence; persistence; adolescent; HUMAN-PAPILLOMAVIRUS INFECTION; RISK HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; COST-EFFECTIVENESS; POSITIVE MEN; SEX; PREVALENCE; VACCINATION; WOMEN; CLEARANCE;
D O I
10.1097/QAI.0000000000002499
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Infection with high-risk human papillomavirus (HR-HPV) has been shown to be more prevalent and persistent in female adolescents with HIV. However, data among male adolescents with perinatally acquired HIV (PHIV) are limited. Setting: We investigated the incidence and persistence of HR-HPV in anogenital compartments and associated factors among PHIV in comparison to HIV-uninfected (HU) male adolescents in Thailand. Methods: PHIV and HU males aged 12-24 years were enrolled. At baseline and 3 subsequent annual visits, specimens from the scrotum, penis, and anal area were obtained for HPV and other testing. Results: From June 2013 to October 2017, 49 PHIV and 47 HU male adolescents with a median age of 18 (interquartile range 17-20) years were enrolled. PHIV had higher incidence of any HR-HPV infection than HU adolescents {33.05 [95% confidence interval (CI): 20.82 to 52.46] vs. 15.73 [95% CI: 8.18 to 30.22] per 100 person-years, P = 0.04}. The persistence of any HR-HPV genotypes (detected at >= 2 annual visits) was not different by group (PHIV 27% vs. HU 23%, P = 0.75). Having >= 3 sex partners in past 6 months (adjusted prevalence ratio 2.39, 95% CI: 1.14 to 5.05; P = 0.02) and co-infection with other sexually transmitted infections (syphilis, chlamydia, and/or gonorrhea) were associated with persistent HR-HPV infection (adjusted prevalence ratio 6.21, 95% CI: 2.87 to 13.41; P < 0.001). Conclusions: Thai PHIV male adolescents had a higher incidence of HR-HPV infection than those without HIV. Having multiple sex partners and co-infection with sexually transmitted infections was associated with persistent HR-HPV infection. These data demonstrate the need to prioritize PHIV male adolescents in routine and catch-up HPV vaccination programs.
引用
收藏
页码:553 / 560
页数:8
相关论文
共 31 条
[1]   Prophylaxis of Cervical Cancer and Related Cervical Disease: A Review of the Cost-Effectiveness of Vaccination Against Oncogenic HPV Types [J].
Armstrong, Edward P. .
JOURNAL OF MANAGED CARE PHARMACY, 2010, 16 (03) :217-230
[2]   Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. [J].
Castellsague, X ;
Bosch, FX ;
Munoz, N ;
Meijer, CJLM ;
Shah, KV ;
de Sanjose, S ;
Eluf-Neto, J ;
Ngelangel, CA ;
Chichareon, S ;
Smith, JS ;
Herrero, R ;
Moreno, V ;
Franceschi, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15) :1105-1112
[3]   Prevalent, persistent anal HPV infection and squamous intraepithelial lesions: Findings from a cohort of men living with HIV in South Africa [J].
Chikandiwa, Admire ;
Pisa, Pedro T. ;
Tamalet, Catherine ;
Muller, Etienne E. ;
Michelow, Pamela ;
Chersich, Matthew F. ;
Mayaud, Philippe ;
Delany-Moretlwe, Sinead .
PLOS ONE, 2019, 14 (12)
[4]   Prevalence of Anal Human Papillomavirus Vaccine Types in the Bangkok Men Who Have Sex With Men Cohort Study [J].
Cranston, Ross D. ;
Althouse, Andrew D. ;
van Griensven, Frits ;
Janocko, Laura ;
Curlin, Marcel E. ;
Chaikummao, Supaporn ;
Chonwattana, Wannee ;
Siegel, Aaron ;
Holtz, Timothy H. ;
McGowan, Ian .
SEXUALLY TRANSMITTED DISEASES, 2015, 42 (12) :671-676
[5]   Prevalence, Clearance, and Incidence of Anal Human Papillomavirus Infection in HIV-Infected Men: The HIPVIRG Cohort Study [J].
de Pokomandy, Alexandra ;
Rouleau, Danielle ;
Ghattas, George ;
Vezina, Sylvie ;
Cote, Pierre ;
Macleod, John ;
Allaire, Guy ;
Franco, Eduardo L. ;
Coutlee, Francois .
JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (07) :965-973
[6]   Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa [J].
Firnhaber, Cynthia ;
Van Le, Hoa ;
Pettifor, Audrey ;
Schulze, Doreen ;
Michelow, Pam ;
Sanne, Ian M. ;
Lewis, David A. ;
Williamson, Anna-Lise ;
Allan, Bruce ;
Williams, Sophia ;
Rinas, Allen ;
Levin, Simon ;
Smith, Jennifer S. .
CANCER CAUSES & CONTROL, 2010, 21 (03) :433-443
[7]   Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors [J].
Geskus, Ronald B. ;
Gonzalez, Cristina ;
Torres, Montserrat ;
Del Romero, Jorge ;
Viciana, Pompeyo ;
Masia, Mar ;
Blanco, Jose R. ;
Iribarren, Mauricio ;
De Sanjose, Silvia ;
Hernandez-Novoa, Beatriz ;
Ortiz, Marta ;
Del Amo, Julia .
AIDS, 2016, 30 (01) :37-44
[8]   Epidemiology of Human Papillomavirus Infection in Men, Cancers other than Cervical and Benign Conditions [J].
Giuliano, Anna R. ;
Tortolero-Luna, Guillermo ;
Ferrer, Elena ;
Burchell, Ann N. ;
de Sanjose, Silvia ;
Kjaer, Susanne Kruger ;
Munoz, Nubia ;
Schiffman, Mark ;
Bosch, F. Xavier .
VACCINE, 2008, 26 :K17-K28
[9]   Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study [J].
Giuliano, Anna R. ;
Lee, Ji-Hyun ;
Fulp, William ;
Villa, Luisa L. ;
Lazcano, Eduardo ;
Papenfuss, Mary R. ;
Abrahamsen, Martha ;
Salmeron, Jorge ;
Anic, Gabriella M. ;
Rollison, Dana E. ;
Smith, Danelle .
LANCET, 2011, 377 (9769) :932-940
[10]   Cost-effectiveness of HPV 16, 18 vaccination in Brazil [J].
Goldie, Sue J. ;
Kim, Jane J. ;
Kobus, Katie ;
Goldhaber-Fiebert, Jeremy D. ;
Salomon, Joshua ;
O'Shea, Meredith K. H. ;
Xavier Bosch, F. ;
de Sanjose, Silvia ;
Franco, Eduardo L. .
VACCINE, 2007, 25 (33) :6257-6270